PVD News

DOCWIRE NEWS

Introduction: Guideline-directed medical therapy (GDMT) is imperative to improve cardiovascular and limb outcomes for patients with critical limb ischemia (CLI), especially amongst those at highest risk for poor outcomes, including those with comorbid chronic kidney disease (CKD). Our objective was to examine GDMT prescription rates and their variation across individual sites for patients with CLI undergoing peripheral vascular interventions (PVIs), by their comorbid CKD status.

CIRCULATION: CARDIOVASCULAR INTERVENTIONS

Background: There are limited data on differences in angiographic distribution of peripheral artery disease and endovascular revascularization strategies in patients presenting with intermittent claudication (IC) and critical limb ischemia (CLI). We aimed to compare anatomic features, treatment strategies, and clinical outcomes between patients with IC and CLI undergoing endovascular revascularization.

DIAGNOSTIC AND INTERVENTIONAL CARDIOLOGY (DAIC)

Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions, announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of IVUS in peripheral vascular disease (PVD) interventions. The new consensus and recommendations for use of IVUS aim to improve quality care in PVD and are based on evidence, expert practice standards, and clinical experience.

CARDIOVASCULAR BUSINESS

Patients with peripheral artery disease (PAD) face an above-average risk of death or adverse outcomes when hospitalized for COVID-19, according to a new analysis published in Current Problems in Cardiology. “COVID-19 is a disease with many diverse manifestations, ranging from asymptomatic disease to mild symptoms, and more severely, thrombotic events, acute respiratory syndrome, and death,” wrote lead author Kim G. Smolderen, PhD, a specialist at Yale University, and colleagues.

THE MEDICAL PROGRESS

Bone marrow derived autologous cell therapy (ACT) has been shown to significantly reduce the rate of major amputation at 5 years in people with diabetes who developed critical limb-threatening ischemia (CLTI). In a study of 130 patients, 64% of 42 patients who were treated conservatively needed a major amputation at 5 years versus just 30% of 45 patients who had been treated with ACT (P = .011).

EXPRESS HEALTHCARE

Royal Philips has announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions. The new consensus and recommendations for use of IVUS aim to improve quality care in PVD and are based on evidence, expert practice standards, and clinical experience.

VASCULAR NEWS

A worldwide committee of 40 cross-speciality medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions.

HematologyAdvisor

A systematic review and meta-analysis found that low-dose rivaroxaban with aspirin was more effective than aspirin alone for reducing major cardiovascular (CV) events and limb outcomes among patients with peripheral artery disease (PAD). Findings of the review were recently published in the European Journal of Preventive Cardiology.

THE KOREAN JOURNAL OF PAIN

Background: The effect of lumbar spinal stenosis (LSS) and peripheral vascular disease (PVD), which occurs with similar degenerative conditions, when seen together, has not been studied. The aim of this study is to examine and compare the relationship between pain, balance, disability, fear of falling, and kinesiophobia in LSS patients with intermittent vascular claudication (IVC).

ScienceDaily

Summary: Researchers have shown that high levels of a specific protein circulating in the blood accurately detect a severe type of peripheral artery disease that narrows the arteries in the legs and can raise the risk of heart attack and stroke.